67 related articles for article (PubMed ID: 30713215)
1. Transcriptome sequencing in a 6-hydroxydopamine rat model of Parkinson's disease.
Li J; Sun Y; Chen J
Genes Genet Syst; 2019 Apr; 94(2):61-69. PubMed ID: 30713215
[TBL] [Abstract][Full Text] [Related]
2. Whole transcriptome sequencing for revealing the pathogenesis of sporotrichosis caused by Sporothrix globosa.
Liu Z; Li SS; Zhang GY; Lv S; Wang S; Li FQ
Sci Rep; 2024 Jan; 14(1):359. PubMed ID: 38172590
[TBL] [Abstract][Full Text] [Related]
3. Biological networks in Parkinson's disease: an insight into the epigenetic mechanisms associated with this disease.
Chatterjee P; Roy D; Bhattacharyya M; Bandyopadhyay S
BMC Genomics; 2017 Sep; 18(1):721. PubMed ID: 28899360
[TBL] [Abstract][Full Text] [Related]
4. Genome-Scale Expression Pattern of Long Non-Coding RNAs in Chinese Uyghur Patients with Parkinson's Disease.
Wang D; Gao H; Li Y; Jiang S; Yong Y; Yang X
Med Sci Monit; 2020 Oct; 26():e925888. PubMed ID: 33031356
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal dysregulation of long non-coding RNAs in Parkinson's disease.
Müller-Nedebock AC; Cuttler K; Pfaff AL; Kõks S
Exp Biol Med (Maywood); 2023 Oct; 248(20):1780-1784. PubMed ID: 37750041
[TBL] [Abstract][Full Text] [Related]
6. Identifying the potential genes in alpha synuclein driving ferroptosis of Parkinson's disease.
Wang M; Li T; Gao R; Zhang Y; Han Y
Sci Rep; 2023 Oct; 13(1):16893. PubMed ID: 37803093
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Long Non-coding RNA Expression Profiles in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease.
Sarıekiz FG; Tomatır AG; Tokgün PE; Bir LS
Mol Neurobiol; 2023 Nov; 60(11):6201-6211. PubMed ID: 37436601
[TBL] [Abstract][Full Text] [Related]
8. Identifying candidate genes associated with hippocampal dysfunction in a hemiparkinsonian rat model by transcriptomic profiling.
Kim B; Hong S; Lee J; Kang S; Kim JS; Jung C; Shin T; Youn B; Moon C
Anim Cells Syst (Seoul); 2024; 28(1):198-215. PubMed ID: 38693920
[TBL] [Abstract][Full Text] [Related]
9. RNA-Seq Analysis Identified XLOC_009190 as Potential Therapeutic Target for Lung Adenocarcinoma.
Wang J; Wang N; Zhao WD; Zhao LX; Jing YG; Yang LJ; He J; Li J
Onco Targets Ther; 2019; 12():11221-11229. PubMed ID: 31908488
[TBL] [Abstract][Full Text] [Related]
10. Discovering Common Pathogenic Mechanisms of COVID-19 and Parkinson Disease: An Integrated Bioinformatics Analysis.
Jahanimoghadam A; Abdolahzadeh H; Rad NK; Zahiri J
J Mol Neurosci; 2022 Nov; 72(11):2326-2337. PubMed ID: 36301487
[TBL] [Abstract][Full Text] [Related]
11. Possible role of lncRNAs in amelioration of Parkinson's disease symptoms by transplantation of dopaminergic cells.
Amini A; Esmaeili F; Golpich M
NPJ Parkinsons Dis; 2024 Mar; 10(1):56. PubMed ID: 38472261
[TBL] [Abstract][Full Text] [Related]
12. An edge-based statistical analysis of long non-coding RNA expression profiles reveals a negative association between Parkinson's disease and colon cancer.
Tian S; Zhang M; Ma Z
BMC Med Genomics; 2021 Feb; 14(1):36. PubMed ID: 33531021
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's Disease and MicroRNAs: A Duel Between Inhibition and Stimulation of Apoptosis in Neuronal Cells.
Saadh MJ; Faisal A; Adil M; Zabibah RS; Mamadaliev AM; Jawad MJ; Alsaikhan F; Farhood B
Mol Neurobiol; 2024 Mar; ():. PubMed ID: 38520611
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNAs in neurodevelopment and Parkinson's disease.
Lyu Y; Bai L; Qin C
Animal Model Exp Med; 2019 Dec; 2(4):239-251. PubMed ID: 31942556
[TBL] [Abstract][Full Text] [Related]
15. Systems biology approach discovers comorbidity interaction of Parkinson's disease with psychiatric disorders utilizing brain transcriptome.
Nashiry MA; Sumi SS; Alyami SA; Moni MA
Front Mol Neurosci; 2023; 16():1232805. PubMed ID: 37654790
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.
Trist BG; Hare DJ; Double KL
Aging Cell; 2019 Dec; 18(6):e13031. PubMed ID: 31432604
[TBL] [Abstract][Full Text] [Related]
17. Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson's disease.
Sarkar S; Nguyen HM; Malovic E; Luo J; Langley M; Palanisamy BN; Singh N; Manne S; Neal M; Gabrielle M; Abdalla A; Anantharam P; Rokad D; Panicker N; Singh V; Ay M; Charli A; Harischandra D; Jin LW; Jin H; Rangaraju S; Anantharam V; Wulff H; Kanthasamy AG
J Clin Invest; 2020 Aug; 130(8):4195-4212. PubMed ID: 32597830
[TBL] [Abstract][Full Text] [Related]
18. A new genetic strategy for targeting microglia in development and disease.
McKinsey GL; Lizama CO; Keown-Lang AE; Niu A; Santander N; Larpthaveesarp A; Chee E; Gonzalez FF; Arnold TD
Elife; 2020 Jun; 9():. PubMed ID: 32573436
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders.
van den Berg MMJ; Krauskopf J; Ramaekers JG; Kleinjans JCS; Prickaerts J; Briedé JJ
Prog Neurobiol; 2020 Feb; 185():101732. PubMed ID: 31816349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
